As part of Johnson & Johnson Medical Device Companies, JJMI is partnering with Karkinos Healthcare, an end-to-end oncology-focused technology platform, to co-create comprehensive solutions to improve the cancer care workforce.
Dr. Basant Garg, Mission Director of Ayushman Bharat Digital Mission and Additional Chief Executive Officer, National Health Authority, in an official letter, appreciated the efforts contributed by Team Karkinos in building the nation’s digital health ecosystem.
This strategic partnership will lay the groundwork for systematic screening for common cancers in Chennai.
The primary aim of this center is to work on research related to advanced and affordable diagnostics solutions for non-communicable diseases, primarily cancer for patients from across the nation.
Karkinos Healthacre will strive to improve the cancer care access and delivery in the state and make a significant impact to the quality of lives of people of West Bengal.
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Police women, participating in the screening program, had access to scientifically advanced cancer diagnostics including the Gold Standard HPV test.
Oncology focused startup Karkinos Healthcare Pvt. Ltd. and premier educational institution Nirmala College of Arts and Science, Mulanthuruthy, Kerala, have signed a Memorandum of Understanding (MoU) agreeing to take cancer prevention and care closer to the citizens.
Four chemotherapy centres have been set up at Lifepoint Hospital Wakad, Meadowlark Hospital Fatimanagar, Kasturba Hospital Vishrantwadi and Sushrut Hospital Kothrud.
The partnership with Westminster Hospital further strengthens our intent to address the cancer burden in citizens across Chennai and Tamil Nadu, especially for those who might otherwise be unable to receive these life-saving facilities.
The joint initiative will provide access to potentially life-saving Cancer Screening facilities to those belonging to economically backward categories, as they are the ones who need such facilities the most, due to a lack of awareness and funds for such tests.
With Endiya Partners’ funding, Karkinos Healthcare is poised to bring about the much-needed disruption in the cancer-care ecosystem with its comprehensive tech-led solutions and distributed network.
Reliance Digital Health Ltd, the wholly owned subsidiary of Reliance Industries Limited, has acquired a minority stake in Karkinos Healthcare.
Karkinos Healthcare in collaboration with the Govt. of Manipur will set up a state-of-the-art greenfield center in a period of eight months from now at the Jawaharlal Nehru Institute of Medical Sciences (JNIMS).
This strategic collaboration will enable continued innovation in cancer care with the goal of transforming cancer care in India and abroad.
Together, Karkinos Healthcare and GenWorks will provide primary screening through HPV DNA tests, and confirmatory diagnoses through colposcopy at the clinics and hospitals of the partner gynecologists.
Karkinos Healthcare closed a funding round with the Tatas Group drawing an investment of Rs 110 crores. Tata Group has disbursed Rs. 35 crores immediately and the rest of the funding is expected to be disbursed in tranches in the coming months.
